At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 85 enrolled
Drug / intervention
Placebo +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Vitamin D on Metabolic Profile in Overweight or Obese Women
In Brief
A Phase 3 clinical trial evaluating Placebo and vitamin D for Overweight and Obesity. Completed, enrolled 85 participants across 1 site.
Detailed Summary
The investigators investigated the effect of vitamin D3 supplementation on metabolic profile (anthropometric measures, blood pressure Lipids, lipoproteins and glycemic indices) in overweight or obese women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOverweight, Obesity
CountriesIran
CollaboratorsShahid Beheshti University of Medical Sciences
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
Primary CompletionFeb 2010
Study CompletionMar 2010
First PostedApr 2011
TodayJul 2026
First PostedApr 28, 2011
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2010
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.2 years ago
Interventions
Placebodietary
dosage form:lactose dosage: 25 micrograms frequency: every day duration: 12weeks
vitamin Ddietary
dosage form:cholecalciferol dosage: 25 micrograms (1000 International Unit) frequency: every day duration: 12weeks